Topics

Companies Related to "Topical Pentoxifylline Gel on Behcet's Disease Genital Ulcers" [Most Relevant Company Matches] RSS

22:25 EST 17th January 2020 | BioPortfolio

Here are the most relevant search results for "Topical Pentoxifylline Gel on Behcet's Disease Genital Ulcers" found in our extensive corporate database of over 50,000 company records.

Showing "Topical Pentoxifylline Behcet Disease Genital Ulcers" Companies 1–25 of 2,900+

Relevant

Biospecifics Technologies Corporation

A pharmaceutical company with a major focus on wound healing and tissue remodeling.Pioneering the application of Collagenase for the treatment of diseases.Dermal ulcers Pressure sores (bedsores) Second and third degree burns Dupuytren's Disease Peyronie's Disease Glaucoma Spinal Disk Disease And Others


Amarillo Biosciences Incorporated

Amarillo Biosciences, Inc., (ABI), is a biopharmaceutical company developing low-dose oral and topical interferon alpha. We are directing our research at the treatment of Behcet's Disease, and oral warts in HIV+ patients and chronic cough in idiopathic pulmonary fibrosis. Low-dose oral interferon is Fundamentally Different from high dose injectable interferon. In this site, we will show the fun...

Athenagen, Inc

Athenagen, Inc., located in South San Francisco, is engaged in the development of small-molecule drugs that act on the nicotinic acetylcholine (nACh) receptor pathway. The company's lead nACh receptor agonists and antagonists are being developed to treat diseases associated with enhanced or impaired angiogenesis and in diseases where cognitive deficit plays a significant role. Athenagen currently ...


Med Discovery SA

Med Discovery’s mission is the discovery and development of highly specific protein drugs to treat uro-genital cancers. By combining biological drug discovery expertise with a strong in-house knowledge of the medical urology field, the Company is uniquely positioned to develop novel drugs for urological cancers and other related solid tumors. Med Discovery wants to become a worldwide leading res...

Oculus Innovative Sciences

Oculus Innovative Sciences is pioneering innovative sciences resulting in breakthrough advances in technology. The revolutionary Microcyn® Technology, the company’s first commercialized technology, is now available in various formulations in the United States. Dermacyn® Wound Care is a super-oxidized solution for moistening, lubricating, cleaning and debriding acute and chronic wounds includin...

Redox Pharmaceutical Corporation

Redox is a bio-pharmaceutical company that has developed chemical compounds shown in preclinical studies to be effective in the treatment and prevention of various viral and inflammatory diseases. Such diseases include ocular herpes, facial herpes and sexually transmitted diseases including genital herpes, genital warts, chlamydia and HIV.

Lotus Tissue Repair, Inc.

Lotus Tissue Repair, Inc. is developing its proprietary recombinant collagen type VII (rC7) technology as a treatment for dermatologic conditions in which rC7 may play an important role in accelerating chronic wound healing, such as diabetic foot ulcers, venous stasis ulcers and similar conditions. The company’s lead program is the first and only prot...

Interferon Sciences Incorporated

Interferon Sciences Incorporated is a biopharmaceutical company engaged in the study, manufacture, and sale of pharmaceutical products based on its highly purified, multispecies, natural source alpha interferon ("NaturalAlpha Interferon"). Interferon Sciences' ALFERON N Injection(R) (Interferon Alfa-n3) product has been approved by the United States Food and Drug Administration ("FDA...

BioVex Inc.

BioVex is a privately held biotechnology company based in Woburn, Mass. where it also has an operational launch grade manufacturing facility. The Company is developing a new class of potent biologics for the treatment of cancer and prevention of infectious disease. In addition to OncoVEX, the Company has a second development program, ImmunoVEX HSV2, ...

Lakewood-Amedex Inc.

Lakewood-Amedex is a privately held development-stage biopharmaceutical company with a broad patent portfolio of inventions, including, 24 granted and/or issued patents and 45 patent applications covering its proprietary NuBiotics family of anti-microbial products, proven to be effective against a wide range of bacteria, encompassing antibiotic resistant strains including methicillin-resistant Sta...

Lakewood-Amedex, Inc.

Lakewood-Amedex is a privately held development-stage biopharmaceutical company with a broad patent portfolio of inventions, including, 24 granted and/or issued patents and 45 patent applications covering its proprietary NuBiotics family of anti-microbial products, proven to be effective against a wide range of bacteria, encompassing antibiotic resistant strains including methicillin-resistant Sta...

ROGAINE

ROGAINE®, one of the brands of McNEIL-PPC, Inc., is the first and ONLY topical brand FDA-approved to regrow hair and the number one dermatologist-recommended brand for hair regrowth. ROGAINE® pioneered the hair regrowth category in 1986 when it was initially launched as an Rx product and has been the sole driver of innovation ever since. ROGAINE® contains minoxidil, the ONLY ingredient FDA-ap...

PellePharm, Inc.

Founded by world leaders in hedgehog pathway signaling, PellePharm, a BridgeBio Company, is committed to targeting rare, genetic dermatological diseases, including Gorlin Syndrome and High Frequency Basal Cell Carcinoma (HF-BCC), at their source. PellePharm’s mission is to improve the quality of life for those suffering from Gorlin Syndrome and HF-BCC...

InterVene Inc.

InterVene Inc. has developed the first non-implantable, catheter-based, vein valve creation therapy. The product is designed to treat chronic venous insufficiency (CVI) in the deep veins - a severely under-treated disease that causes painful venous stasis ulcers and other debilitating symptoms in millions of Americans annually. For more information, visit www....

PellePharm

Founded by world leaders in hedgehog signaling, PellePharm, a BridgeBio company, is committed to targeting rare genetic dermatological conditions, including Gorlin Syndrome and Basal Cell Carcinomas (BCCs), at the source. PellePharm is committed to improving the quality of life for those suffering from Gorlin Syndrome and BCCs by providing an easy-to-use t...

TGR BioSciences Pty Ltd

We have a particular interest in gut and skin disorders where products can be delivered locally by ingestion or by topical application. Where possible, we take these products to market as dietary supplements, medical foods or skin care products because the time and cost to market is much less than with drugs.Our products include novel milk-derived bioactive extracts as ingredients for cosmetic and...

Dermira, Inc.

Dermira is a private, development-stage company focused on developing and commercializing innovative new therapies in dermatology. Dermira was founded by an experienced management team and is advancing a robust pipeline of innovative topical compounds addressing key areas of need in dermatology. The Company’s portfolio of dermatology therapeutics incl...

Dermira

Dermira is a development-stage, private company focused on developing and commercializing innovative new therapies in dermatology. Dermira was founded by an experienced management team and owns and licenses a robust pipeline of innovative topical compounds addressing key areas of need in dermatology. The Company’s portfolio of dermatology therapeutics ...

Anacor Pharmaceuticals, Inc

We have synthesized a class of compounds with characteristics that make them especially attractive for the topical treatment of onychomycosis. In particular, AN2690 penetrates the nail 200 times better than the only U.S. Food and Drug Administration-approved topical onychomycosis treatment. AN2690 potently inhibits Trichophyton rubrum and Trichophyton mentagrophytes, which are the two major fungi ...

The National Verruca Foundation

The National Verruca Foundation was established to provide accurate information and increase awareness of non-genital warts. Through education and advocacy, we hope to improve the management and prevention of the human papillomavirus (HPV).

National Verruca Foundation

The National Verruca Foundation was established to provide accurate information and increase awareness of non-genital warts. Through education and advocacy, we hope to improve the management and prevention of the human papillomavirus (HPV).

Nventa Biopharmaceuticals Corporation

Nventa Biopharmaceuticals Corporation (TSX:NVN) is developing innovative therapeutics for the treatment of viral infections, with a focus on diseases caused by the human papillomavirus (HPV). Our lead therapeutic candidate is HspE7, a novel therapeutic vaccine designed for the treatment of diseases caused by the human papillomavirus (HPV), one of the most common sexually transmitted diseases in ...

MC2 Therapeutics A/S

MC2 Therapeutics A/S is a privately held pharmaceutical company that is applying its proprietary PAD™ Technology as a broad platform to enable the development of a new generation of patient friendly topical prescriptions and consumer healthcare products. The Company is advancing its own portfolio of products to treat skin and eye conditions and is col...

Sinclair Pharma Plc

Sinclair Pharma plc is an international specialty pharmaceutical company focused on the sourcing and acquisition of innovative products, registration and commercialisation of those products.Sinclair currently focuses in dermatology, oral health and ophthalmology. The company is experiencing strong sales growth, particularly for its main products Aloclair (mouth ulcers), Atopiclair (eczema/atopic d...

Kedalion Therapeutics, Inc.

Kedalion Therapeutics is a venture-backed, clinical-stage biotechnology company whose mission is to bring to market transformative topical ophthalmic therapies for new and existing indications. Kedalion’s proprietary AcuStream platform technology delivers topical drugs to the eye in a precise and accurate manner that enables comparable effect with up ...


More From BioPortfolio on "Topical Pentoxifylline Gel on Behcet's Disease Genital Ulcers"

Quick Search

Corporate Database Quicklinks